2012 annual financial data
Capricor Therapeutics 2012 Operating margin
Direct answer
Operating margin was -1,248.08%.
Operating income was -2,440,000 USD and net income was -1,893,000 USD.
Operating cash flow was -2,186,681 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 195,500 USD
- Operating income
- -2,440,000 USD
- Net income
- -1,893,000 USD
- Operating cash flow
- -2,186,681 USD